HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Mauer Selected Research

Losartan (Cozaar)

1/2019Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 Diabetes.
2/2016Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
2/2014The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure.
2/2013Angiotensin II blockade in kidney transplant recipients.
1/2012Angiotensin II receptor blocker pretreatment of rats undergoing sudden renal ablation.
7/2009Renal and retinal effects of enalapril and losartan in type 1 diabetes.
9/2007Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats.
12/2002ACE-I and ARBs in early diabetic nephropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Mauer Research Topics

Disease

33Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 05/2002
25Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 12/2002
12Fabry Disease (Fabry's Disease)
01/2022 - 12/2010
6Albuminuria
04/2022 - 03/2003
6Type 2 Diabetes Mellitus (MODY)
01/2021 - 01/2011
6Chronic Kidney Failure (Chronic Renal Failure)
01/2018 - 12/2002
5Chronic Renal Insufficiency
10/2020 - 05/2010
5Hypoglycemia (Reactive Hypoglycemia)
06/2014 - 08/2009
5Hypertension (High Blood Pressure)
02/2014 - 02/2002
4Proteinuria
02/2014 - 09/2007
3Fibrosis (Cirrhosis)
04/2022 - 03/2003
3Disease Progression
01/2019 - 12/2010
3Insulin Resistance
06/2016 - 07/2008
2Diabetic Retinopathy (Retinopathy, Diabetic)
08/2011 - 02/2006
1Diabetes Complications
01/2019
1Sclerosis
02/2016
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2016
1Inborn Genetic Diseases (Disease, Hereditary)
01/2016
1Stroke (Strokes)
01/2016
1Inflammation (Inflammations)
04/2015
1Kidney Diseases (Kidney Disease)
08/2013
1Lactic Acidosis
08/2009
1Chronic Cough
07/2009
1Cat-Scratch Disease
02/2007
1Nephritis
03/2006
1Headache (Headaches)
12/2004
1Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
12/2004
1Papilledema
12/2004
1Ureteral Obstruction
03/2003

Drug/Important Bio-Agent (IBA)

11AlbuminsIBA
01/2019 - 05/2002
8Losartan (Cozaar)FDA LinkGeneric
01/2019 - 12/2002
6Biomarkers (Surrogate Marker)IBA
04/2022 - 12/2002
6CreatinineIBA
01/2019 - 05/2010
5globotriaosylceramide (globotriosylceramide)IBA
01/2022 - 03/2011
5Uric Acid (Urate)IBA
10/2020 - 08/2013
4Allopurinol (Remid)FDA LinkGeneric
10/2020 - 01/2018
4GalactosidasesIBA
01/2018 - 05/2013
4GlycosphingolipidsIBA
01/2018 - 05/2013
3Proteins (Proteins, Gene)FDA Link
01/2020 - 12/2010
3agalsidase betaFDA Link
01/2019 - 03/2012
3Advanced Glycation End ProductsIBA
12/2016 - 10/2013
3EnalaprilFDA LinkGeneric
07/2009 - 12/2002
2Hemoglobins (Hemoglobin)IBA
04/2022 - 02/2016
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2019 - 06/2013
2EnzymesIBA
11/2017 - 11/2006
2Cystatin CIBA
08/2017 - 06/2014
2ReninIBA
02/2014 - 08/2011
2Tacrolimus (Prograf)FDA LinkGeneric
02/2014 - 01/2011
2Pyruvaldehyde (Methylglyoxal)IBA
10/2013 - 11/2005
2Angiotensin IIIBA
02/2013 - 09/2004
2Indicators and Reagents (Reagents)IBA
12/2010 - 06/2002
2Angiotensin Receptor AntagonistsIBA
02/2010 - 12/2002
2Retinaldehyde (Retinal)IBA
02/2010 - 07/2009
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
02/2010 - 12/2002
2LipidsIBA
07/2008 - 02/2006
2Antihypertensive Agents (Antihypertensives)IBA
05/2003 - 12/2002
1MicroRNAs (MicroRNA)IBA
01/2021
1Biological ProductsIBA
10/2019
1CollagenIBA
10/2019
1inositol pentaphosphate (inositol pentakisphosphate)IBA
11/2018
1inositol 1,3,4,5,6-pentakisphosphate 2-kinaseIBA
11/2018
1Immunoglobulin G (IgG)IBA
01/2018
1migalastatIBA
11/2017
1BradykininIBA
01/2017
1Peptides (Polypeptides)IBA
01/2017
1KininsIBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
06/2015
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
04/2015
1HepcidinsIBA
04/2015
1AldosteroneIBA
02/2014
1HLA Antigens (Human Leukocyte Antigens)IBA
02/2014
1Sirolimus (Rapamycin)FDA Link
02/2014
1AutoantibodiesIBA
11/2013
1cyclo(Arg-Pro) (CI 4)IBA
03/2012
1AngiotensinsIBA
08/2011
1CalcineurinIBA
01/2011
1olmesartanIBA
01/2011
1EndoglinIBA
07/2010
1Insulin (Novolin)FDA Link
07/2008
1Azithromycin (Zithromax)FDA LinkGeneric
02/2007
1CatalaseIBA
11/2006
1Messenger RNA (mRNA)IBA
11/2006
1AntioxidantsIBA
11/2006
1Glutathione PeroxidaseIBA
11/2006
1Immunoglobulin A (IgA)IBA
03/2006
13-deoxyglucosoneIBA
11/2005
1Streptozocin (Streptozotocin)FDA Link
09/2004
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
03/2003

Therapy/Procedure

6Glycemic Control
01/2019 - 02/2002
4Kidney Transplantation
04/2017 - 12/2004
4Enzyme Replacement Therapy
01/2016 - 03/2012
4Therapeutics
01/2016 - 05/2003
4Pancreas Transplantation
06/2014 - 01/2011
2Transplantation
06/2014 - 01/2012
2Nephrectomy
01/2012 - 03/2003
1Heart Transplantation (Grafting, Heart)
01/2016
1Time-to-Treatment
01/2016
1Renal Dialysis (Hemodialysis)
01/2016
1Islets of Langerhans Transplantation
01/2012
1Aftercare (After-Treatment)
02/2007